Diabetes, Heart and Cardiovascular Diseases News Chronicle Diabetes, Cardiovascular and Heart Diseases. Article 52
Published on September 4, 2016 at 11:30 AM


About Long Rapid Short Intermediate Insulin From Novo Nordisk

There are basically 4 types of insulin

Long acting insulin and short acting insulin are not compatible each other and so not possible to combine them in a single injection. But Danish based Novo Nordisk company developed co-formulation of both types of insulin in a single pen device. This co-formulation will simplify insulin treatment with fewer injections, flexible, affordable, convenient for people with diabetes.


       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Oral Insulin Based On Cholestosome Technology
2. Insulin Benefits With Fig Leaves
3. Device To Release Drugs In Eye
4. Device To Predict Diabetes
5. Diabetes Link To Episodic Memory Decline
6. Study Of Limb Ischemia CLI
7. Risks To Heart Attack And Diabetes Before Menopause

 

About T-Cells And c-Rel Protein
White blood cells are broadly of two types and both of them helps our body immune system. Bone marrow develops one type of white cell and it is known as "B-cells". B-cells job is to produce antibodies. A lymphoid organ in vertebrates produces another type of white cells and known as T-cells (or T-lymphocytes). T-cells job is body immune response. T-cells again can be classified as

c-Rel is a protein plays important role in B-cells production and survival.


Type 1 diabetes (T1D) is an autoimmune disease that affects 5% of the population and more than 30 million in U.S. citizens affected by diabetes. Type 1 diabetes (T1D) impairs T-cells or T-lymphocytes cells those are circulating in the body. When T-cells are impaired, subsets of T-cells are unchecked and destroy needed body cells such as insulin producing beta cells in pancreas. With the destruction of insulin producing beta cells, an individual will be affected by type 1 diabetes (T1D).

A study done by researchers from the Case Western Reserve University, Cleveland Ohio identified root cause for abnormal immune response for the type i diabetes (T1D). Researchers created genetically engineered mice model for the c-Rel protein experiment. Researchers says

Lead author of the study was Dr Parameswaran Ramakrishnan Ph.D and the study findings were published in Diabetes.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Exercise Benefits With Keratin Derived Protein Extract
2. Study Of TSPAN2 Protein
3. Device To Detect Deadly Ketones
4. About Revita DMR Device
5. Study On Diabetic retinopathy
6. Diabetes Amputations In UK
7. Study Of Liraglutide Drug On Heart Failure

 

Categories

Sitemap 1   Sitemap 2   Sitemap 3   Sitemap 4

 

Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.


Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.